Corbus Pharmaceuticals (NASDAQ:CRBP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Performance Shares of NASDAQ CRBP opened at $5.55 on Friday. The company has a market cap of $24.53 million, a PE ratio […]

Related Keywords

,Dimensional Fund Advisors ,News Ratings For Corbus Pharmaceuticals Daily ,Corbus Pharmaceuticals Company Profile ,Corbus Pharmaceuticals ,Corbus Pharmaceuticals Holdings Inc ,Corbus Pharmaceuticals Stock Performance ,Institutional Investors Weigh In On Corbus Pharmaceuticals ,Sio Capital Management ,Blackrock Inc ,Vident Investment Advisory ,Free Report ,Get Free Report ,Fund Advisors ,Street Corp ,Investment Advisory ,Pharmaceuticals Holdings ,Corbus Pharmaceuticals Daily ,Nasdaq Crbp ,Crbp ,Medical ,Initiated Coverage ,Stocknews Com ,